Hillsdale Investment Management’s CRH Medical Corporation CRHM Stock Holding History

Hillsdale Investment Management’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,200	Closed	-$17K	–	684
2020 Q2	$17K	Sell	8,200 -264,703	-97%	-$535K	﹤0.01%	470
2020 Q1	$364K	Sell	272,903 -41,297	-13%	-$135K	0.04%	348
2019 Q4	$1.09M	Buy	314,200 +161,200	+105%	+$509K	0.09%	180
2019 Q3	$470K	Buy	+153,000	New	+$454K	0.04%	365
2018 Q4	–	Sell	-258,900	Closed	-$1.03M	–	670
2018 Q3	$1.03M	Hold	258,900	–	–	0.14%	146
2018 Q2	$810K	Buy	+258,900	New	+$826K	0.1%	167
2017 Q3	–	Sell	-328,788	Closed	-$1.87M	–	544
2017 Q2	$1.87M	Hold	328,788	–	–	0.37%	46
2017 Q1	$2.68M	Buy	328,788 +3,200	+1%	+$22.1K	0.53%	38
2016 Q4	$1.74M	Buy	+325,588	New	+$1.65M	0.36%	48
2016 Q3	–	Sell	-941,200	Closed	-$3.66M	–	577
2016 Q2	$3.66M	Buy	+941,200	New	+$3.08M	1.07%	24
2015 Q4	–	Sell	-9,200	Closed	-$29K	–	615
2015 Q3	$29K	Buy	+9,200	New	+$33.3K	0.01%	431

Other funds holding CRHM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hillsdale Investment Management's CRHM Position: Q3 2020 in Review

Hillsdale Investment Management sold out of CRH Medical Corporation (CRHM) in Q3 2020, closing a stake of 8,200 shares — an estimated $17K sold.

Hillsdale Investment Management first reported a position in CRHM in Q3 2015 and held it in 11 quarters. The position peaked at $3.66M in Q2 2016. 41 funds tracked by Wall St. Rank hold CRHM as of Q3 2020.

Hillsdale Investment Management reported no remaining CRH Medical Corporation position as of Q3 2020 after selling out during the quarter.
Hillsdale Investment Management sold 8,200 CRH Medical Corporation shares in Q3 2020, an estimated $17K.
Hillsdale Investment Management first reported a position in CRH Medical Corporation in Q3 2015 and held it in 11 quarters.
Hillsdale Investment Management's CRH Medical Corporation position peaked at $3.66M in Q2 2016.
41 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q3 2020.

Based on Hillsdale Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.